Presentations and Postersby Voluntary Organization JBCRG
2005
Feasibility and efficacy of phase II trial of sequential preoperative FEC 100 followed by Docetaxel 100 in primary operable breast cancer.
Nakamura S, Masuda N, Iwata H, Toi M, Kuroi K, Akiyama F; Japan Breast Cancer Research Group (JBCRG)
2nd Organisation for Oncology and Translational Research, Tokyo, Nov. 2005